Key result
Primary aldosteronism spans a continuous disease spectrum driven by distinct histopathological and genotypic features.
Why the study?
Primary aldosteronism is a common, under-recognised cause of hypertension with excess cardiovascular and renal risk, requiring accurate subtype diagnosis to guide treatment.
This review highlights that primary aldosteronism is a continuous spectrum rather than a binary disorder, emphasizing the role of tissue biology and genotype in shaping clinical outcomes.
Answers are grounded in this paper and cite their sources.
Challenges binary classification of primary aldosteronism; leaves open whether spectrum-based subtyping improves outcomes beyond current PASO/PAMO criteria.
Primary aldosteronism (PA) is a common, under-recognised cause of hypertension carrying cardiovascular and renal risk beyond blood pressure alone. Management requires accurate subtype diagnosis: lateralised disease may be cured by adrenalectomy, whereas bilateral disease usually requires mineralocorticoid receptor antagonist therapy. The PASO criteria standardised postsurgical outcome assessment and showed that biochemical remission is achieved in most patients with adrenal vein sampling-confirmed lateralised disease, whereas clinical remission is variable, reflecting pre-existing hypertensive burden, age and sex. The PAMO criteria extend this framework to medically treated PA and show that complete clinical response is uncommon. At the tissue level, the HISTALDO classification distinguishes classical lateralised disease, typically caused by an aldosterone-producing adenoma, from non-classical disease, dominated by multiple micronodules; the latter carries a higher risk of postsurgical persistent or recurrent aldosteronism. These observations support a broader model in which PA forms a continuous rather than binary spectrum, from subclinical renin-independent aldosteronism and age-related micronodular remodelling to overt bilateral and lateralised disease. Tissue omics studies support a model in which aldosterone-producing lesions progress from zona glomerulosa cells to micronodules and adenomas. KCNJ5-mutated adenomas may follow a direct route, arising without a detectable micronodule stage, possibly because reduced oxidative stress favours early cell survival and expansion. The adenoma is therefore not a static endpoint but a maturing tissue, in which immune remodelling and changes in cell-survival mechanisms may shape progression towards a hypersecretory state. Together, these findings link clinical phenotype to adrenal tissue biology and support a dynamic, genotype-modulated model of PA pathogenesis.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2026) conducted a review in Primary aldosteronism. Primary aldosteronism was evaluated. Primary aldosteronism forms a continuous spectrum from subclinical renin-independent aldosteronism to overt bilateral and lateralised disease, driven by distinct histopathological and genotypic features.
Synapse has enriched 10 related papers. Consider them for comparative context: